1. lékařská fakulta Univerzity Karlovy Univerzita Karlova
Zajímá vás, co se děje na fakultě? Přihlaste se k odběru bulletinu Jednička.

Pomůžeme vám

Potřebujete pomoc nebo informace a nevíte přesně na koho se obrátit?

Kontaktujte nás

XIMBIO - Your Global Reagents Partner

  • World’s largest non-profit organisation dedicated to commercial use of life science laboratory research tools, reagents, and materials 
  • Wholly owned subsidiary of Cancer Research UK 
  • Partnerships with more than 150 Technology Transfer Offices, over 2000 researchers and more than 200 life science companiesworldwide


Partnership with Charles University 

  • Sale of compounds and other research tools developed at CUNI through Ximbio’s portfolio (Ximbio.com) 
  • Ximbio pays CUNI 60 % of revenue generated by offered compounds
    • Researchers are entitled to up to 55 % of the received sum based on Rector’s Directive No. 46/2018 
  • Requires minimum effort on researcher’s side 
    • Preparation of compounds in required commercial amounts takes place in Ximbio’s labs based on provided preparation protocols
  • Opportunity to repurpose compounds and tools developed in research projects and with no further use 
    • Interest in compounds and tools both with and without IP protection


Ximbio’s Portfolio
  • Monoclonal Antibodies 
  • Polyclonal Antibodies
  • Cell Lines
  • Mouse Models
  • Small Molecules
  • Vectors
  • Peptides and Proteins
  • Zebrafish
  • Recombinant Antibodies
  • Lab Consumables
  • Bacteria

What Is Required to Provide?
  • Structure or any other form of characterisation of offered research tools
  • Preparation protocols
  • Optional: 
    • Small samples for analyses
    • Can be crude (Ximbio will purify them themselves)
    • Data from analyses, biological testing, etc.
    • Information on original intended use and other potential applications
    • Information on expected biological activity
    • Other available relevant documentation


Dr. Antonín Králík
Analyst and Patent Specialist
Phone: +420 771 134 090
E-Mail: kralik@cuip.cz



Hodnocení: spravovat